Herd Immunity to Hepatitis B in the Russian Federation in 2017–2019

Herd Immunity to Hepatitis B in the Russian Federation in 2017–2019

Relevance. Hepatitis B is a global problem of global and Russian public health due to its high prevalence and the possibility of forming a chronic form of the disease with the development of cirrhosis and hepatocellular carcinoma. Aims. Assessment of the herd immunity to hepatitis B in the populati...

Full description

Bibliographic Details
Main Authors:	S. N. Kuzin, T. A. Semenenko, V. V. Klushkina, N. V. Vlasenko, N. S. Churilova, Ya. V. Panasyuk, E. N. Kudryavtseva, M. I. Korabel'nikova, D. V. Dubodelov, Z. S. Rodionova, G. G. Solopova, M. V. Konopliova, I. G. Nikitin, N. I. Shulakova, A. V. Tutelian, V. G. Akimkin
Format:	Article
Language:	Russian
Published:	Numikom LLC 2022-05-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	hepatitis b serological monitoring population immunity post-vaccination immunity epidemiological surveillance anti-hbs
Online Access:	https://www.epidemvac.ru/jour/article/view/1519

Similar Items

Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
by: D. V. Solov’yov, et al.
Published: (2024-11-01)

Evaluation of the epidemiological significance of molecular genetic factors in relation to the intensity of post-vaccination immunity against hepatitis B
by: N. V. Vlasenko, et al.
Published: (2022-05-01)

Modern views on the role of <i>X</i> gene of the hepatitis B virus (<i>Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus</i>) in the pathogenesis of the infection it causes
by: Y. V. Panasiuk, et al.
Published: (2022-03-01)

Single nucleotide polymorphisms of the interleukin-1 superfamily members: аssociation with viral hepatitis B and C
by: N. V. Vlasenko, et al.
Published: (2021-05-01)

Results of screening for antibodies to varicella-zoster virus in healthcare workers of a multidisciplinary hospital in Moscow
by: Nataliya M. Afonina, et al.
Published: (2024-01-01)

Assessment of the COVID-19 epidemiological situation in St. Petersburg
by: V. G. Akimkin, et al.
Published: (2021-11-01)

Distribution of Major Histocompatibility Complex Alleles in Cohorts of Patients with Different Levels of Post-Vaccination Antibodies against Hepatitis B
by: N. V. Vlasenko, et al.
Published: (2024-07-01)

Genetic Factors for the Natural Elimination of Hepatitis C Virus
by: N. V. Vlasenko, et al.
Published: (2023-05-01)

Epidemiological and Immunological Efficacy of Health Workers Vaccination against Hepatitis B
by: V. G. Akimkin, et al.
Published: (2017-08-01)

Hepatitis C in immunocompromised pediatric patients: an epidemiological analysis of data from a center of pediatric hematology, oncology and immunology
by: Satsuk A.V., et al.
Published: (2021-12-01)

Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China
by: Yijun Wang, et al.
Published: (2023-12-01)

The Structure of Hepatitis C Virus Genotypes/Subtypes in Adult Patients with Chronic Hepatitis C in the Moscow Region
by: E. N. Kudryavtseva, et al.
Published: (2016-04-01)

Immunological Susceptibility of Metropolis Population to Measles in its Elimination Stage
by: A. V. Nozdracheva, et al.
Published: (2019-05-01)

Seroprevalence of Measles, Rubella and Mumps Antibodies in Foreign Citizens Registered in Moscow Region (Labour Migrants)
by: T. A. Semenenko, et al.
Published: (2017-06-01)

Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
by: Abdulbasit R. N. Abuzwaida, et al.
Published: (1987-08-01)

Gender-Age Distribution of Patients with COVID-19 at Different Stages of Epidemic in Moscow
by: V. G. Akimkin, et al.
Published: (2020-10-01)

Evaluation of Post-Vaccination Immunity in Children and Adolescents after Viral Hepatitis B Vaccine
by: Anna A. Khamidulina, et al.
Published: (2024-02-01)

Distribution of human gene polymorphisms allele frequencies associated with viral infections
by: Natalia V. Vlasenko, et al.
Published: (2023-11-01)

Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies
by: Maria V. Konopleva, et al.
Published: (2021-05-01)

ANTIBODY TITER AGAINST HBSAGIN CHILDREN ENTERING ELEMENTARY SCHOOL WHO WERE VACCINATED AGAINST HEPATITIS B AT BIRTH: SBAHR.E.KORD CITY
by: K MOSTAFAVIZADEH, et al.
Published: (2001-09-01)

Key aspects of occupational risks for healthcare workers
by: N.I. Shulakova, et al.
Published: (2024-06-01)

Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts
by: Nikolaos Papadopoulos, et al.
Published: (2021-11-01)

T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs
by: Qiao Zhan, et al.
Published: (2022-06-01)

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
by: G. N. Leonova, et al.
Published: (2014-07-01)

СYTOKINES IN OROPHARYNGEAL LAVAGES FROM THE PATIENTS WITH CHRONIC ADENOIDITIS IN THE COURSE OF LOCAL MONOTHERAPY WITH IMUNOPHAN
by: R. N. Kuznetsova, et al.
Published: (2014-07-01)

PATTERN OF LOCAL IMMUNE ALTERATIONS IN THE PATIENTS WITH CHRONIC ADENOIDITIS, AND AN OPPORTUNITY OF THEIR CORRECTION WITH IMUNOFAN
by: R. N. Kuznetsova, et al.
Published: (2014-07-01)

How does the immunogenicity of hepatitis B vaccine change over the years in childhood?
by: Gulsum Iclal Bayhan, et al.
Published: (2021-08-01)

Risks of HAIs: problems and pitfalls
by: N.I. Shulakova, et al.
Published: (2023-06-01)

IS IT NECESSARY TO VACCINATE CHILDREN AGAINST HEPATITIS A ROUTINELY IN PRESENT TIME? THE EVALUATION OF RESULTS OF SUCH STRATEGY OF HEPATITIS A VACCINE PROPHYLAXIS IN SELECTED REGIONS OF THE RUSSIAN FEDERATION
by: I. V. Shakhgildian, et al.
Published: (2014-06-01)

Anxiety disorders in children with attention  deficit/hyperactivity disorder
by: E.A. Korabel’nikova
Published: (2020-12-01)

Treatment of insomnia in patients with neurotic disorders. Demyelinating diseases
by: E. A. Korabel'nikova
Published: (2015-12-01)

EVALUATION OF INTENSITY OF HUMORAL IMMUNITY TO MEASLES AND RUBELLA IN PREGNANT WOMEN IN MOSCOW
by: A. V. Nozdracheva, et al.
Published: (2017-06-01)

Study of the adjuvant properties of beta-glucans from <i>Saccharomyces Cerevisiae</i> yeast
by: Ekaterina A. Volosnikova, et al.
Published: (2024-07-01)

Application of the wax moth (Galeria melonella) larvae extract for correction of the immune status of athletes during the recovery period
by: L. V. Barabash, et al.
Published: (2020-08-01)

ROLE OF HUMORAL IMMUNE FACTORS IN ELIMINATION OF TICK-BORNE ENCEPHALITIS VIRUS IN NON-VACCINATED PERSONS, AND IN THOSE VACCINATED AGAINST TICK-BORNE ENCEPHALITIS
by: N. V. Krylova, et al.
Published: (2014-07-01)

Induction of Innate and Adaptive Immune Response against Recombinant HBsAg Protein Entrapped in Docosahexaenoic Acid Nanovesicles through Biomarkers
by: Mohammed Ali Bakkari, et al.
Published: (2023-02-01)

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
by: Tung-Hung Su, et al.
Published: (2012-07-01)

Comparison of anti-HBs persistence after hepatitis B vaccination on two-dose schedule and three-dose schedule among adults: results from a 12-year follow up study in China
by: Jingjing Lu, et al.
Published: (2019-05-01)

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
by: Luna Colagrossi, et al.
Published: (2018-06-01)

The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy
by: Yingfu Zeng, et al.
Published: (2024-03-01)